Your email has been successfully added to our mailing list.

×
0 0 0 0 -0.0368095238095239 -0.0314269841269841 -0.0004761904761906 -0.0288888888888889
Stock impact report

AzurRx up 7% in inclusion of TDN sites in cystic fibrosis study [Seeking Alpha]

AzurRx BioPharma, Inc. (AZRX) 
Last azurrx biopharma, inc. earnings: 11/14 04:31 pm Check Earnings Report
Company Research Source: Seeking Alpha
AzurRx BioPharma (AZRX+7.3%announcesTDN is a 91-center collaborative network of CF clinical trial specialists supported by the Cystic Fibrosis Foundation.The company expects to complete the enrollment of 30 subjects by Q4 with topline data expected in Q1 2021.An earlier Phase 2,OPTIONfailed to demonstrateMS1819 is an orally available recombinant lipase derived from the yeastYarrowia Lipolytica Show less Read more
Impact Snapshot
Event Time:
AZRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AZRX alerts
Opt-in for
AZRX alerts

from News Quantified
Opt-in for
AZRX alerts

from News Quantified